FDA Releases Clinical Hold on $JUNO Drug, Stock Surges

Three days ago, the day traders at the FDA put a hold on this drug, due to it killing a few people. Today, they removed it! How wonderful.

The co announced that the UFDA has removed the clinical hold on the Phase II clinical trial of JCAR015 (known as the “ROCKET” trial) in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (r/r ALL). Under the revised protocol, the ROCKET trial will continue enrollment using JCAR015 with cyclophosphamide pre-conditioning only.

As a result, the stock is fucking soaring through the rafters. Perhaps someone had a sit down with the FDA about their ‘uninformed decision’ to erroneously and maliciously placing a clinical hold on such a drug? For JUNO shareholders, it’s a very good thing the fuckers at the FDA came to their senses (extra Joe Pesci).

JUNO is higher by 30% in the after hours.